Follow Us on StockTwits

Huron Consulting Beats on Earnings and Revenue

Posted by on May 1, 2017 7:45 AM
Tags: , , , , , , , , ,
Categories: Stocks

May 01, 2017: Huron Consulting Group reports Q1 EPS of $0.55 versus the $0.54 estimate. Revenue also beat coming in at $188.8 million versus the $177 million estimate.

The CEO Jim Roth said, “As we expected, our Education and Life Sciences and Business Advisory segments achieved strong results in the first quarter, while our Healthcare segment remained challenged.”

January 9, 2017: Huron Consulting Group formed a doji today, in oversold territory, on news it acquired Pope Woodhead & Associates. Huron Consulting Group says that it has expanded its life sciences strategy expertise with the acquisition of Pope Woodhead & Associates. The UK-based consulting firm provides market access capabilities to assist clients in developing value propositions for innovative medicines and technologies. The acquisition strengthens the firms ability to lead clients through complex payer and regulatory environments across the global healthcare community.

Pope Woodhead, based in Cambridge, England, partners with the top global pharmaceutical companies as well as biotech and medical device organizations to bring to market therapies that improve patients health. The firms knowledge of global, regional and local markets and deep understanding of the value of their clients innovations have made them a preferred partner of many life sciences organizations.

For reporting purposes, Pope Woodhead will be included in Hurons Education and Life Sciences operating segment. Terms of the stock purchase transaction were not disclosed.

Huron Consulting Group Stock Chart

The Finviz screener settings used to find Huron Consulting Group are: P/E Low (<15), Forward P/E Low (<15), EPS growth this year High (>25%), EPS growth past 5 years High (>25%), RSI (14) Oversold (40), Candlestick Doji

Huron Consulting Group helps clients in diverse industries improve performance, transform the enterprise, reduce costs, leverage technology, process and review large amounts of complex data, address regulatory changes, recover from distress and stimulate growth.


Follow me

Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on unless specifically stated in the article. Owner of Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.
Follow me